PARP Inhibitors in Advanced Prostate Cancer: Overcoming Global Challenges in Testing and Treatment

Learn strategies to optimize treatment with PARP inhibitors for patients with advanced prostate cancer, including biomarker testing to inform therapy choice and current guideline recommendations, through a certified on-demand webcast with accompanying downloadable slides, a ClinicalThought commentary, and an infographic.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.